chr4-55396322-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 4P and 2B. PM1PM2BP4_Moderate
The ENST00000381334.10(TMEM165):c.133G>C(p.Glu45Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000381334.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM165 | NM_018475.5 | c.133G>C | p.Glu45Gln | missense_variant | 1/6 | ENST00000381334.10 | NP_060945.2 | |
TMEM165 | XM_011534394.4 | c.133G>C | p.Glu45Gln | missense_variant | 1/6 | XP_011532696.1 | ||
TMEM165 | XM_017008412.2 | c.-313G>C | 5_prime_UTR_variant | 1/8 | XP_016863901.1 | |||
TMEM165 | NR_073070.2 | n.366G>C | non_coding_transcript_exon_variant | 1/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM165 | ENST00000381334.10 | c.133G>C | p.Glu45Gln | missense_variant | 1/6 | 1 | NM_018475.5 | ENSP00000370736 | P1 | |
TMEM165 | ENST00000506198.5 | c.133G>C | p.Glu45Gln | missense_variant | 1/3 | 2 | ENSP00000425449 | |||
TMEM165 | ENST00000514070.1 | n.72G>C | non_coding_transcript_exon_variant | 1/2 | 2 | |||||
TMEM165 | ENST00000508404.5 | c.133G>C | p.Glu45Gln | missense_variant, NMD_transcript_variant | 1/7 | 2 | ENSP00000422639 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2021 | The c.133G>C (p.E45Q) alteration is located in exon 1 (coding exon 1) of the TMEM165 gene. This alteration results from a G to C substitution at nucleotide position 133, causing the glutamic acid (E) at amino acid position 45 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.